The value of approved therapies for pulmonary arterial hypertension

Am Heart J. 2007 Jun;153(6):889-90. doi: 10.1016/j.ahj.2007.03.001.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Calcium Channel Blockers / therapeutic use
  • Epoprostenol / administration & dosage
  • Epoprostenol / analogs & derivatives
  • Epoprostenol / therapeutic use
  • Exercise Therapy
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / therapy
  • Infusions, Intravenous
  • Meta-Analysis as Topic
  • Research Design

Substances

  • Calcium Channel Blockers
  • beraprost
  • Epoprostenol